See analyst estimates and all valuation multiples for Small Molecules
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $3.7B | 35.4x | -47.8x | |
| $3.5B | 7.7x | 20.0x | |
| $3.5B | 19.5x | 59.9x | |
| $2.6B | 3.3x | 18.6x | |
| $2.3B | 87.3x | -65.8x | |
| $2.1B | 12.0x | -7.0x | |
| $1.8B | 6.7x | 16.8x | |
| $1.8B | 0.7x | 5.4x | |
| $1.2B | 5.6x | 27.0x | |
| $1.2B | 5.3x | 15.3x | |
| $939M | n/a | n/a | |
| $838M | n/a | n/a | |
| $800M | 3.9x | 16.5x | |
| $745M | 3.3x | 35.8x | |
| $653M | 7.4x | 21.1x | |
| $496M | 43.1x | -2.7x | |
| $478M | 5.9x | n/a | |
| $313M | 1.6x | 5.9x | |
| $205M | 5.4x | n/a | |
| $194M | 2.7x | -2.7x | |
| $171M | 6.2x | -7.1x | |
| $129M | n/a | n/a | |
| $129M | n/a | -5.8x | |
| $126M | 1.3x | -15.3x | |
| $117M | n/a | -27.0x | |
| $78.1M | n/a | -0.6x | |
| $27.0M | 0.3x | -0.6x | |
| $11.3M | 0.3x | n/a | |
| -$29.3M | -1.0x | 0.3x | |
| -$33.6M | -10.0x | n/a | |
| -$37.7M | n/a | n/a | |
| -$70.2M | n/a | 0.6x | |
| -$202M | -6.3x | 0.9x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Small Molecules